Evidence map›Paper›PMID 22403702›Full record

Trial reportPloS one2012

Interplay of filaggrin loss-of-function variants, allergic sensitization, and eczema in a longitudinal study covering infancy to 18 years of age.

Ali H Ziyab, Wilfried Karmaus, Mitra Yousefi, Susan Ewart, Eric Schauberger, John W Holloway, Hongmei Zhang, Syed Hasan Arshad

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Skin barrier-related genes in childhood atopic dermatitis, asthma, and allergy: A systematic review and meta-analysis.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Pooled it
  2. Trial
  3. Article
  4. Revisiting the Roles of Filaggrin in Atopic Dermatitis.International journal of molecular sciences · 2022
    Review
  5. Sex-specific developmental trajectories of eczema from infancy to age 26 years: A birth cohort study.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022
    Article
  6. Current insights into the genetics of food allergy.The Journal of allergy and clinical immunology · 2021
    Review
  7. Review
  8. Breastfeeding duration modifies the effect of smoking during pregnancy on eczema from early childhood to adolescence.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2018
    Article
  9. Observational
  10. Article
  11. Filaggrin mutations increase allergic airway disease in childhood and adolescence through interactions with eczema and aeroallergen sensitization.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2018
    Article
  12. Article
  13. Article
  14. Allergic sensitization and filaggrin variants predispose to the comorbidity of eczema, asthma, and rhinitis: results from the Isle of Wight birth cohort.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2014
    Article
  15. Article
  16. Article
  17. DNA methylation of the filaggrin gene adds to the risk of eczema associated with loss-of-function variants.Journal of the European Academy of Dermatology and Venereology : JEADV · 2013
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Ali H ZiyabDepartment of Epidemiology and Biostatistics, Norman J Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, United States of America.
Wilfried Karmaus
Mitra Yousefi
Susan Ewart
Eric Schauberger
John W Holloway
Hongmei Zhang
Syed Hasan Arshad
University of South Carolina · USMichigan United · USDavid Hide Asthma and Allergy Research Centre · GBUniversity of Southampton · GB

Funding

Transgenerational epigenetic inheritance of allergy in a multigenerational cohortR01AI091905 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KARMAUS, WILFRIED JJ · 2011 to 2015
$2.7M
Genetic &epidemiologic cohort study of asthma &allergyR01AI061471 · NIAID · MICHIGAN STATE UNIVERSITY · PI EWART, SUSAN L · 2005 to 2009
$1.8M
Epidemiology of asthma: risk and prognosis in a cohort from birth to adolescenceR01HL082925 · NHLBI · ST. MARY'S HOSPITAL NEWPORT · PI ARSHAD, SYED HASAN · 2007 to 2010
$1.7M
NHLBI NIH HHS R01 HL082925NIAID NIH HHS R01 AI061471NIAID NIH HHS R01 AI091905NIAID NIH HHS R01AI091905
6 · The paper itself

Abstract

backgroundImmune specific genes as well as genes regulating the formation of skin barrier are major determinants for eczema manifestation. There is a debate as to whether allergic sensitization and filaggrin gene (FLG) variants lead to eczema or FLG variants and eczema increase the risk of allergic sensitization. To investigate the time-order between eczema and allergic sensitization with respect to FLG variants, data from a large prospective study covering infancy to late adolescence were analyzed. METHODOLOGY/PRINCIPAL

findingsRepeated measurements of eczema and allergic sensitization (documented by skin prick tests) at ages 1, 2, 4, 10, and 18 years were ascertained in the Isle of Wight birth cohort (n = 1,456). Three transition periods were analyzed: age 1-or-2 to 4, 4 to 10, and 10 to 18 years. FLG variants were genotyped in 1,150 participants. Over the three transition periods, in temporal sequence analyses of initially eczema-free participants, the combined effect of FLG variants and allergic sensitization showed a 2.92-fold (95% CI: 1.47-5.77) increased risk ratio (RR) of eczema in subsequent examinations. This overall risk was more pronounced at a younger age (transition period 1-or-2 to 4, RR = 6.47, 95% CI: 1.96-21.33). In contrast, FLG variants in combination with eczema showed a weaker, but significant, risk ratio for subsequent allergic sensitization only up to 10 years of age. CONCLUSIONS/SIGNIFICANCE: Taking the time order into account, this prospective study demonstrates for the first time, that a combination of FLG variants and allergic sensitization increased the risk of eczema in subsequent years. Also FLG variants interacted with eczema and increased the risk of subsequent allergic sensitization, which, was limited to the younger age. Hence, early restoration of defective skin barrier could prevent allergic sensitization and subsequently reduce the risk of eczema development.

Indexed as

Genetic VariationAdolescentChildChild, PreschoolEczemaFemaleFilaggrin ProteinsGenetic Predisposition to DiseaseHumansHypersensitivityInfantInfant, NewbornIntermediate Filament ProteinsLongitudinal StudiesMaleTime FactorsFilaggrin ProteinsFLG protein, humanIntermediate Filament Proteins

Identifiers

PMID22403702
PMCPMC3293849
OpenAlexW2056973588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.